Candidate molecular alterations associated with potential resistance in KRAS G12D gastrointestinal cancers

被引：0
|
作者：
Jazieh, Khalid
Tsai, Jill
Solomon, Sheila R.
Xie, Hao
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Guardant Hlth, Redwood City, CA USA
[3] Guardant Hlth Inc, Redwood City, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3519
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.
    Jazieh, Khalid
    Tsai, Jill
    Zhu, Mojun
    Xie, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 170 - 170
  • [2] The clinical and genomic characteristics of KRAS G12D mutated cancers
    Lin, Guomin
    Yuan, Shaohua
    Pang, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Site-specific mutagenesis screening in KRAS G12D mutant library to uncover resistance mechanisms to KRAS G12D inhibitors
    Choi, Jeesoo
    Shin, Ju-young
    Kim, Taeyul K.
    Kim, Kiwook
    Kim, Jiyun
    Jeon, Eunhye
    Park, Juyeong
    Han, Yoon Dae
    Kim, Kyung-A
    Sim, Taebo
    Kim, Hui Kwon
    Kim, Han Sang
    CANCER LETTERS, 2024, 591
  • [4] Phase 2 Trial of Bortezomib in KRAS G12D Mutant Lung Cancers
    Riely, Gregory J.
    Litvak, Anya
    Rekhtman, Natasha
    Pietanza, M. Catherine
    Chaft, Jamie E.
    Woo, Kaitlin
    Paik, Paul
    Miller, Vincent
    Kris, Mark G.
    Rodriguez, K.
    Drilon, Alexander
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S663 - S663
  • [5] Phase II trial of bortezomib in KRAS G12D mutant lung cancers.
    Litvak, Anna Maria
    Drilon, Alexander E.
    Rekhtman, Natasha
    Pietanza, Maria Catherine
    Chaft, Jamie E.
    Woo, Kaitlin
    Paik, Paul K.
    Kris, Mark G.
    Riely, Gregory J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
    Sofiani, Vahideh Hamidi
    Shiadeh, Arefeh Ebrahimian
    Tabarraei, Alijan
    Nikoo, Hadi Razavi
    Sadeghi, Farzin
    Kamrani, Ghodsieh
    Yahyapour, Yousef
    Moradi, Abdolvahab
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (12)
  • [7] Inhibition of KRAS G12D mutant with small molecules
    Lee, Dae-Hee
    Lee, Ji Yoon
    CANCER RESEARCH, 2024, 84 (06)
  • [8] KRAS G12D mutation in Brunner gland adenoma
    Ortega, Mahatma
    Sparks, Jessica
    Lichy, Jack
    Nava, Victor E.
    BMJ CASE REPORTS, 2023, 16 (01)
  • [9] Overcoming Cell Subtype-Specific Adaptive Resistance to KRAS G12D Inhibition in KRAS G12D-Mutant Pancreatic Cancer
    Lin, Qingxiang
    Morales, Alvin
    Barnes, Haley
    Corcoran, Ryan Bruce
    CANCER RESEARCH, 2024, 84 (17)
  • [10] Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
    Till, Jacob E.
    McDaniel, Lee
    Chang, Changgee
    Long, Qi
    Pfeiffer, Shannon M.
    Lyman, Jaclyn P.
    Padron, Lacey J.
    Maurer, Deena M.
    Yu, Jia Xin
    Spencer, Christine N.
    Gherardini, Pier Federico
    Da Silva, Diane M.
    LaVallee, Theresa M.
    Abbott, Charles
    Chen, Richard O.
    Boyle, Sean M.
    Bhagwat, Neha
    Cannas, Samuele
    Sagreiya, Hersh
    Li, Wenrui
    Yee, Stephanie S.
    Abdalla, Aseel
    Wang, Zhuoyang
    Yin, Melinda
    Ballinger, Dominique
    Wissel, Paul
    Eads, Jennifer
    Karasic, Thomas
    Schneider, Charles
    O'Dwyer, Peter
    Teitelbaum, Ursina
    Reiss, Kim A.
    Rahma, Osama E.
    Fisher, George A.
    Ko, Andrew H.
    Wainberg, Zev A.
    Wolff, Robert A.
    O'Reilly, Eileen M.
    O'Hara, Mark H.
    Cabanski, Christopher R.
    Vonderheide, Robert H.
    Carpenter, Erica L.
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345